[3] The American Diabetes Association recommends reassessing glycemic control approximately three months after initiating or adjusting glucose-lowering therapy, though preliminary assessment of tolerability and response can occur earlier
Probe trials on day 9 consistently showed that high doses of Dihexa, regardless of administration method, significantly increased time spent in the target quadrant compared to scopolamine-impaired groups, indicating preserved learned task memory
While peptide therapy may be appropriate for some individuals, it is not necessarily suitable for everyone
It should be avoided in patients with severe gastrointestinal disorders such as gastroparesis, as delayed gastric emptying may worsen symptoms[13]
Prevalence of polycystic ovary syndrome (PCOS) and its associated hormonal and comorbid risk factors in northeast india: a cross-sectional comparative study
Feb 1 2019;104(2):369-378